Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
529 News Items found
SKI Developmental Biology Program Chair Kat Hadjantonakis
2nd Annual Kravis Woman in Science Endeavor Symposium Held at Memorial Sloan Kettering

The event featured scientific talks from leading women in science, including winners of this year’s Kravis WiSE fellowships.
MSK molecular biologist Agnel Sfeir
Exploring the ‘Forgotten Genome’ and More: At Work with Molecular Biologist Agnel Sfeir

Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
Feature
Developmental biologist Kathryn Anderson
In Memoriam: Developmental Biologist Kathryn V. Anderson

Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
To Improve Immunotherapy, Researchers Look to Shift Immune Cells’ Access to Sugar

More sugar available for immune cells could mean better immune responses against cancer.
Hans-Guido Wendel
Tree-Derived Cancer Drug Shows Promise in Treating COVID-19 Virus

Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.
In the Lab
Physician-scientist Alex Kentsis
Research Shows How Common Feature of Blood Cancers Can Be Targeted

Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
Direna Alonso Curbelo
Sloan Kettering Institute Scientists Learn How Genes and Environment Conspire in Pancreatic Cancer Development

The insights lay the groundwork for earlier diagnosis and better treatment of the disease.
MSK immunologist Ming Li
Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer

Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
Francisco Sánchez-Rivera
Confronting a Crisis: How MSK Cancer Geneticists Responded to COVID-19

During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.